Ibrahim Akkawi
Research Subjects
Ibrahim Akkawi has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Hassan Zmerly
Link Campus University, Rome, Italy
9 shared publications - Francesco Pegreffi
Department of Medicine and Surgery, School of Medicine and Surgery, “Kore” University of Enna, 94100 Enna, Italy
3 shared publications Manuela Moscato
Orthopaedics and Traumatology Unit, Villa Erbosa Hospital, Bologna, Italy
3 shared publications- Manuela Moscato
San Pier Damiano Hospital, Faenza (RA).
3 shared publications - Hassan Zmerly
Orthopaedics and Traumatology Unit, Villa Erbosa Hospital, Bologna, Italy.
2 shared publications - Maurizio Draghetti
Orthopaedics and Traumatology Unit, Villa Erbosa Hospital, Bologna, Italy.
2 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Bentham Science Publishers Ltd. in Current Rheumatology Reviews
- Vol. 22 (1) , 113-117
Uncommon Presentation of Giant Tophaceous Gout in the Hand: A Case Report
Background: Tophaceous gout masses are characterized by the accumulation of monosodium urate crystals in peripheral joints and soft tissues. The most commonly involved areas are the metatarsophalangeal and knee joints. Finger/hand localization is uncommon. If not correctly treated, a finger tophaceous mass can grow and, in rare cases, reach an abnormally large size, termed “giant.” Aim: The aim of our study is to present a rare case of a large tophaceous mass of the hand, localized in the fourth finger, and to highlight the role of surgical excision combined with a multidisciplinary team approach. Case Report: We present a rare case of an 82-year-old woman affected by giant tophaceous gout in the left hand, localized to the extensor region of the proximal interphalangeal joint of the fourth finger. Clinical evaluation, MRI, and ultrasound imaging showed a 35 x 30 mm nodule in the soft tissue. The lesion was successfully treated by mass excision and debridement of the extensor tendon. Histopathologic examination confirmed the diagnosis of tophaceous gout. Post-operatively, a combination of medical and nutritional therapy was given. At a 3-year follow-up, the patient was free of symptoms with no evidence of disease in the fourth finger. Conclusion: Management of giant tophaceous gout in hand necessitates extensive mass excision combined with pharmacological therapy, dietary adjustments, and lifestyle modifications. Effective treatment of such cases requires a multidisciplinary team approach to address the complexity of the condition comprehensively.
- 1 January 2026
- Published by Bentham Science Publishers Ltd. in Current Rheumatology Reviews
- Vol. 22 (1) , 113-117
Open AccessUncommon Presentation of Giant Tophaceous Gout in the Hand: A Case Report
Background: Tophaceous gout masses are characterized by the accumulation of monosodium urate crystals in peripheral joints and soft tissues. The most commonly involved areas are the metatarsophalangeal and knee joints. Finger/hand localization is uncommon. If not correctly treated, a finger tophaceous mass can grow and, in rare cases, reach an abnormally large size, termed “giant.” Aim: The aim of our study is to present a rare case of a large tophaceous mass of the hand, localized in the fourth finger, and to highlight the role of surgical excision combined with a multidisciplinary team approach. Case Report: We present a rare case of an 82-year-old woman affected by giant tophaceous gout in the left hand, localized to the extensor region of the proximal interphalangeal joint of the fourth finger. Clinical evaluation, MRI, and ultrasound imaging showed a 35 x 30 mm nodule in the soft tissue. The lesion was successfully treated by mass excision and debridement of the extensor tendon. Histopathologic examination confirmed the diagnosis of tophaceous gout. Post-operatively, a combination of medical and nutritional therapy was given. At a 3-year follow-up, the patient was free of symptoms with no evidence of disease in the fourth finger. Conclusion: Management of giant tophaceous gout in hand necessitates extensive mass excision combined with pharmacological therapy, dietary adjustments, and lifestyle modifications. Effective treatment of such cases requires a multidisciplinary team approach to address the complexity of the condition comprehensively.
- Open Access
- 29 September 2025
- Published by Open Medical Publishing in Orthopedic Reviews
- Vol. 17
Defining the boundaries of surgery in pediatric ACL avulsion fractures: A Case Report in a 5-Year-Old Child
Anterior cruciate ligament (ACL) avulsion fracture is an uncommon injury in the pediatric population, typically involving a bony avulsion at the tibial insertion of the ligament. Diagnosis is usually established on plain radiographs, particularly in the lateral view, and further characterized by magnetic resonance imaging (MRI). Treatment may be conservative or surgical, depending on the degree of displacement and rotation of the bony fragment according to the Meyers and McKeever (MM) classification, as well as the presence of associated soft-tissue injuries. However, the optimal management of Type II fractures remains debated, making individual case reports valuable to guide clinical decision-making. We report the case of a five-year-old child with a Type II MM ACL avulsion fracture managed successfully with conservative treatment. The patient was immobilized in extension with a long leg cast for 30 days, and follow-up imaging demonstrated complete healing without complications. At two-year follow-up, clinical examination confirmed full recovery with a stable knee and no residual laxity. This case emphasizes that, in the absence of concomitant intra-articular lesions on MRI, conservative management can represent a safe and effective option for Type II ACL avulsion fractures in very young patients.
- 29 September 2025
- Published by Open Medical Publishing in Orthopedic Reviews
- Vol. 17
Open AccessDefining the boundaries of surgery in pediatric ACL avulsion fractures: A Case Report in a 5-Year-Old Child
Anterior cruciate ligament (ACL) avulsion fracture is an uncommon injury in the pediatric population, typically involving a bony avulsion at the tibial insertion of the ligament. Diagnosis is usually established on plain radiographs, particularly in the lateral view, and further characterized by magnetic resonance imaging (MRI). Treatment may be conservative or surgical, depending on the degree of displacement and rotation of the bony fragment according to the Meyers and McKeever (MM) classification, as well as the presence of associated soft-tissue injuries. However, the optimal management of Type II fractures remains debated, making individual case reports valuable to guide clinical decision-making. We report the case of a five-year-old child with a Type II MM ACL avulsion fracture managed successfully with conservative treatment. The patient was immobilized in extension with a long leg cast for 30 days, and follow-up imaging demonstrated complete healing without complications. At two-year follow-up, clinical examination confirmed full recovery with a stable knee and no residual laxity. This case emphasizes that, in the absence of concomitant intra-articular lesions on MRI, conservative management can represent a safe and effective option for Type II ACL avulsion fractures in very young patients.
- 16 September 2025
- Published by Bentham Science Publishers Ltd. in Current Stem Cell Research & Therapy
- Vol. 20 (3) , 1-5
Cartilage Repair and Symptom Relief After Autologous Microfragmented Adipose-Derived Mesenchymal Stem Cell Therapy in Hip Osteoarthritis: A Case Report with Histological Correlation
Introduction: Intra-articular injection of autologous microfragmented adipose-derived mesenchymal stem cells (AMSCs) has shown potential for symptom relief and cartilage regeneration in osteoarthritis (OA). However, histological evidence in humans remains limited. Case Presentation: We present a 46-year-old female patient who had symptomatic left hip OA and underwent a single injection of autologous microfragmented AMSCs under ultrasound guidance after unsuccessful hip arthroscopy. At the 12-month follow-up, the patient was pain-free, fully mobile, and had returned to normal daily activities without limitations, indicating an excellent clinical outcome. Eighteen months after the treatment, due to symptom recurrence, the patient later underwent total hip arthroplasty, allowing histological analysis of the joint. Examination revealed areas of hyaline-like cartilage in regions previously affected by degeneration. Conclusion: This case provides clinical and histological evidence of cartilage regeneration following intra-articular autologous microfragmented AMSCs therapy for hip OA. Although symptom recurrence occurred at 18 months, findings suggest this treatment may offer a regenerative option warranting further study.
- 16 September 2025
- Published by Bentham Science Publishers Ltd. in Current Stem Cell Research & Therapy
- Vol. 20 (3) , 1-5
Cartilage Repair and Symptom Relief After Autologous Microfragmented Adipose-Derived Mesenchymal Stem Cell Therapy in Hip Osteoarthritis: A Case Report with Histological Correlation
Introduction: Intra-articular injection of autologous microfragmented adipose-derived mesenchymal stem cells (AMSCs) has shown potential for symptom relief and cartilage regeneration in osteoarthritis (OA). However, histological evidence in humans remains limited. Case Presentation: We present a 46-year-old female patient who had symptomatic left hip OA and underwent a single injection of autologous microfragmented AMSCs under ultrasound guidance after unsuccessful hip arthroscopy. At the 12-month follow-up, the patient was pain-free, fully mobile, and had returned to normal daily activities without limitations, indicating an excellent clinical outcome. Eighteen months after the treatment, due to symptom recurrence, the patient later underwent total hip arthroplasty, allowing histological analysis of the joint. Examination revealed areas of hyaline-like cartilage in regions previously affected by degeneration. Conclusion: This case provides clinical and histological evidence of cartilage regeneration following intra-articular autologous microfragmented AMSCs therapy for hip OA. Although symptom recurrence occurred at 18 months, findings suggest this treatment may offer a regenerative option warranting further study.
- Open Access
- 29 August 2025
- Published by Open Medical Publishing in Orthopedic Reviews
- Vol. 17, 143566
Preoperative strategies to prevent periprosthetic joint infection after knee replacement: evidence-based recommendations for multidisciplinary practice
Periprosthetic joint infection (PJI) is a severe and challenging complication following joint replacement that significantly impacts patient outcomes and implant longevity. Various factors contribute to PJI onset, including patient-related comorbidities and surgical procedures. Preventive strategies are categorized into preoperative, perioperative, and postoperative measures. Preoperative risk factors can be classified as general or local. General ones include comorbidity management (metabolic disorder, rheumatic and inflammatory diseases), nutritional optimization, weight control, bacterial decolonization, and lifestyle modifications. Local factors involve avoiding intra-articular injections before surgery and assessing previous knee interventions, in addition to implementing preoperative physiotherapy and ensuring proper skin preparation. Preoperative patient optimization significantly improves outcomes following knee replacement by reducing PJI risk, as well as hospital stays and recovery times. Implementing standardized, evidence-based preoperative strategies can enhance surgical success and long-term implant survival. Multidisciplinary collaboration between surgeons, general practitioners, and healthcare providers is essential to minimize infection risks and improve patient outcomes following joint replacement. This paper focuses on preoperative optimization, highlighting evidence-based recommendations to minimize the risk of PJI in patients undergoing knee replacement.
- 29 August 2025
- Published by Open Medical Publishing in Orthopedic Reviews
- Vol. 17, 143566
Open AccessPreoperative strategies to prevent periprosthetic joint infection after knee replacement: evidence-based recommendations for multidisciplinary practice
Periprosthetic joint infection (PJI) is a severe and challenging complication following joint replacement that significantly impacts patient outcomes and implant longevity. Various factors contribute to PJI onset, including patient-related comorbidities and surgical procedures. Preventive strategies are categorized into preoperative, perioperative, and postoperative measures. Preoperative risk factors can be classified as general or local. General ones include comorbidity management (metabolic disorder, rheumatic and inflammatory diseases), nutritional optimization, weight control, bacterial decolonization, and lifestyle modifications. Local factors involve avoiding intra-articular injections before surgery and assessing previous knee interventions, in addition to implementing preoperative physiotherapy and ensuring proper skin preparation. Preoperative patient optimization significantly improves outcomes following knee replacement by reducing PJI risk, as well as hospital stays and recovery times. Implementing standardized, evidence-based preoperative strategies can enhance surgical success and long-term implant survival. Multidisciplinary collaboration between surgeons, general practitioners, and healthcare providers is essential to minimize infection risks and improve patient outcomes following joint replacement. This paper focuses on preoperative optimization, highlighting evidence-based recommendations to minimize the risk of PJI in patients undergoing knee replacement.
- 22 February 2025
- Published by Springer Nature in MUSCULOSKELETAL SURGERY
- Vol. 109 (4) , 411-416
Outcome of total knee arthroplasty in patients with Blount disease or Blount-like deformity: a systematic review
Blount disease is a genetic disorder affecting the proximal tibial bone, resulting in a complex deformity of the knee. In the absence of timely treatment, the likelihood of developing degenerative arthritis increases. A total knee arthroplasty (TKA) is the conventional treatment for adult patients with Blount disease or Blount-like deformity with advanced degenerative changes. The aim of this systematic review is to evaluate the results of TKA in this particular cohort of patients. The present systematic review comprised a total of 5 articles. The 5 evaluated studies included data from 9 patients who undergone 12 TKAs. The patients were assessed throughout an average follow-up duration of 4 years. In all, there were three revisions of the prosthetic components. All studies achieved successful clinical scores at the last follow-up. A thorough exploration of PubMed, Embase, and Web of Science was conducted to identify research that documented the results of TKA in patients diagnosed with Blount disease or Blount-like deformity. TKA in patients with Blount disease or Blount-like deformities is intricate and demanding. Constrained implants can effectively mitigate the possible problem of persistent instability. Notwithstanding the unfavorable circumstances, TKA in this cohort of patients appears to yield satisfactory outcomes during the short- to medium-term period of observation. Other study is necessary to establish the enduring outcomes of TKA in this particular cohort of patients.
- 22 February 2025
- Published by Springer Nature in MUSCULOSKELETAL SURGERY
- Vol. 109 (4) , 411-416
Outcome of total knee arthroplasty in patients with Blount disease or Blount-like deformity: a systematic review
Blount disease is a genetic disorder affecting the proximal tibial bone, resulting in a complex deformity of the knee. In the absence of timely treatment, the likelihood of developing degenerative arthritis increases. A total knee arthroplasty (TKA) is the conventional treatment for adult patients with Blount disease or Blount-like deformity with advanced degenerative changes. The aim of this systematic review is to evaluate the results of TKA in this particular cohort of patients. The present systematic review comprised a total of 5 articles. The 5 evaluated studies included data from 9 patients who undergone 12 TKAs. The patients were assessed throughout an average follow-up duration of 4 years. In all, there were three revisions of the prosthetic components. All studies achieved successful clinical scores at the last follow-up. A thorough exploration of PubMed, Embase, and Web of Science was conducted to identify research that documented the results of TKA in patients diagnosed with Blount disease or Blount-like deformity. TKA in patients with Blount disease or Blount-like deformities is intricate and demanding. Constrained implants can effectively mitigate the possible problem of persistent instability. Notwithstanding the unfavorable circumstances, TKA in this cohort of patients appears to yield satisfactory outcomes during the short- to medium-term period of observation. Other study is necessary to establish the enduring outcomes of TKA in this particular cohort of patients.
- Open Access
- 5 December 2023
- Vol. 94 (6) , e2023240
Outcome of simultaneous bi-unicompartmental knee arthroplasty: a systematic review.
Simultaneous medial and lateral tibiofemoral osteoarthritis (OA) could be treated with bi-unicompartmental knee arthroplasty (Bi-UKA) as an alternative to total knee arthroplasty (TKA). The present systematic review aims to assess if simultaneous Bi-UKA is a feasible option for treating medial and lateral tibiofemoral OA. A comprehensive search of PubMed, MEDLINE, Cochrane Library, and Google Scholar was performed to find studies that reported on the outcome of simultaneous Bi-UKA for both medial and lateral tibiofemoral OA. Seven studies were considered eligible for inclusion in the present systematic review. Intraoperative fractures occurred 8 times. Overall, there were 22 revisions of the prosthetic components for any reason with a survival rate that ranged from 83 to 100%. Of these, 16 revisions were for the aseptic loosening of the prosthetic components. Out of 302 surgeries, three were revised due to symptomatic OA progression in the patello-femoral joint. All clinical scores improved at the latest follow-up compared to preoperative values. Moreover, there were no differences in clinical scores of Bi-UKA compared to unicompartmental knee arthroplasty (UKA), or medial UKA plus patello-femoral prosthesis. Whereas, compared to TKA, Bi-UKA patients had comparable or superior scores. Finally, the Bi-UKA group had a significantly shorter hospital stay compared to the TKA group. The use of simultaneous Bi-UKA is a valid option to address bicompartmental knee OA in selected patients with low intraoperative fracture rate, low revision rate, satisfactory clinical outcome, and fast recovery.
- 5 December 2023
- Vol. 94 (6) , e2023240
Open AccessOutcome of simultaneous bi-unicompartmental knee arthroplasty: a systematic review.
Simultaneous medial and lateral tibiofemoral osteoarthritis (OA) could be treated with bi-unicompartmental knee arthroplasty (Bi-UKA) as an alternative to total knee arthroplasty (TKA). The present systematic review aims to assess if simultaneous Bi-UKA is a feasible option for treating medial and lateral tibiofemoral OA. A comprehensive search of PubMed, MEDLINE, Cochrane Library, and Google Scholar was performed to find studies that reported on the outcome of simultaneous Bi-UKA for both medial and lateral tibiofemoral OA. Seven studies were considered eligible for inclusion in the present systematic review. Intraoperative fractures occurred 8 times. Overall, there were 22 revisions of the prosthetic components for any reason with a survival rate that ranged from 83 to 100%. Of these, 16 revisions were for the aseptic loosening of the prosthetic components. Out of 302 surgeries, three were revised due to symptomatic OA progression in the patello-femoral joint. All clinical scores improved at the latest follow-up compared to preoperative values. Moreover, there were no differences in clinical scores of Bi-UKA compared to unicompartmental knee arthroplasty (UKA), or medial UKA plus patello-femoral prosthesis. Whereas, compared to TKA, Bi-UKA patients had comparable or superior scores. Finally, the Bi-UKA group had a significantly shorter hospital stay compared to the TKA group. The use of simultaneous Bi-UKA is a valid option to address bicompartmental knee OA in selected patients with low intraoperative fracture rate, low revision rate, satisfactory clinical outcome, and fast recovery.
- 23 June 2023
- Vol. 94 (S2) , e2023086
Treatment of a subcutaneous tibialis anterior tendon rupture with a semitendinosus autograft.
The subcutaneous rupture of the tibialis anterior tendon is a rare and silent lesion which can lead to foot and ankle dysfunction with gait difficulty. The treatment can be either conservative or surgical. Conservative management is reserved for inactive patients and those with a general or local contraindication to surgery, whereas surgical repair includes direct and rotational suture, as well as tendon transfer and auto- or allograft. The choice of surgical treatment is based on multiple factors, including the symptoms, the timespan from injury to treatment, the anatomopathological pattern of the lesion, and the patient's age and level of activity. Large defects present a particular reconstructive challenge, and there is no consensus on the optimal method of treatment. That being said, one of the options is an autograft using the semitendinosus hamstring tendon. We present a case of a 69-year-old woman who sustained a hyperflexion trauma to her left ankle. Three months later, ultrasound examination and a magnetic resonance imaging showed a complete tibialis anterior rupture with a gap of more than 10 cm. The patient was successfully treated with surgical repair. An autograft of the semitendinosus tendon was used to bridge the gap. The tibialis anterior rupture is a rare lesion that must be promptly diagnosed and treated, especially in physically active patients. Large defects pose particular challenges. Surgical management was found to be the treatment of choice. In the case of a lesion with a major gap, semitendinosus grafting can be successfully employed.
- 23 June 2023
- Vol. 94 (S2) , e2023086
Treatment of a subcutaneous tibialis anterior tendon rupture with a semitendinosus autograft.
The subcutaneous rupture of the tibialis anterior tendon is a rare and silent lesion which can lead to foot and ankle dysfunction with gait difficulty. The treatment can be either conservative or surgical. Conservative management is reserved for inactive patients and those with a general or local contraindication to surgery, whereas surgical repair includes direct and rotational suture, as well as tendon transfer and auto- or allograft. The choice of surgical treatment is based on multiple factors, including the symptoms, the timespan from injury to treatment, the anatomopathological pattern of the lesion, and the patient's age and level of activity. Large defects present a particular reconstructive challenge, and there is no consensus on the optimal method of treatment. That being said, one of the options is an autograft using the semitendinosus hamstring tendon. We present a case of a 69-year-old woman who sustained a hyperflexion trauma to her left ankle. Three months later, ultrasound examination and a magnetic resonance imaging showed a complete tibialis anterior rupture with a gap of more than 10 cm. The patient was successfully treated with surgical repair. An autograft of the semitendinosus tendon was used to bridge the gap. The tibialis anterior rupture is a rare lesion that must be promptly diagnosed and treated, especially in physically active patients. Large defects pose particular challenges. Surgical management was found to be the treatment of choice. In the case of a lesion with a major gap, semitendinosus grafting can be successfully employed.
- 25 April 2022
- Published by Open Medical Publishing in Orthopedic Reviews
- Vol. 14 (2) , 33639
Treatment options for secondary osteonecrosis of the knee
Knee osteonecrosis is a debilitating progressive degenerative disease characterized by subchondral bone ischemia. It can lead to localized necrosis, tissue death, and progressive joint destruction. For this reason, it is essential to diagnose and treat this disease early to avoid subchondral collapse, chondral damage, and end-stage osteoarthritis, where the only solution is total knee arthroplasty. Three types of knee osteonecrosis have been documented in the literature: spontaneous or primitive, secondary, and post arthroscopy. Spontaneous osteonecrosis is the most common type studied in the literature. Secondary osteonecrosis of the knee is a rare disease and, unlike the spontaneous one, involves patients younger than 50 years. It presents a particular set of pathological, clinical, imaging, and progression features. The management of secondary osteonecrosis is determined by the stage of the disorder, the clinical manifestation, the size and location of the lesions, whether the involvement is unilateral or bilateral, the patient’s age, level of activity, general health, and life expectancy. This review aims to present the recent evidence on treatment options for secondary osteonecrosis of the knee, including conservative treatment, joint preserving surgery, and knee replacement.
- 25 April 2022
- Published by Open Medical Publishing in Orthopedic Reviews
- Vol. 14 (2) , 33639
Treatment options for secondary osteonecrosis of the knee
Knee osteonecrosis is a debilitating progressive degenerative disease characterized by subchondral bone ischemia. It can lead to localized necrosis, tissue death, and progressive joint destruction. For this reason, it is essential to diagnose and treat this disease early to avoid subchondral collapse, chondral damage, and end-stage osteoarthritis, where the only solution is total knee arthroplasty. Three types of knee osteonecrosis have been documented in the literature: spontaneous or primitive, secondary, and post arthroscopy. Spontaneous osteonecrosis is the most common type studied in the literature. Secondary osteonecrosis of the knee is a rare disease and, unlike the spontaneous one, involves patients younger than 50 years. It presents a particular set of pathological, clinical, imaging, and progression features. The management of secondary osteonecrosis is determined by the stage of the disorder, the clinical manifestation, the size and location of the lesions, whether the involvement is unilateral or bilateral, the patient’s age, level of activity, general health, and life expectancy. This review aims to present the recent evidence on treatment options for secondary osteonecrosis of the knee, including conservative treatment, joint preserving surgery, and knee replacement.
- Open Access
- 14 March 2022
- Vol. 93 (1) , e2022135
Minimally manipulated adipose derived mesenchymal stromal cells and osteoarthritis: A narrative review.
Human mesenchymal stromal cells (MSCs) have increasingly been used to treat osteoarthritis (OA) related pain and dysfunction, due to their capacity for regeneration and anti-inflammatory effects. Adipose-derived MSCs are characterized by their abundance, ease of access, easy isolation procedures, high lipoaspirate stromal cell production, quicker multiplication of cells, and less pain and morbidity during harvesting. These cells are typically enzymatically derived from adipose tissue but this technique has complicated regulatory problems. To address this problem, a new technique has been created to extract and process adipose tissue without expansion and the use of enzymes to produce autologous minimally manipulated adipose-derived MSCs. Recent studies have confirmed that this treatment is an effective and promising method for treating pain and improving joint function in patients affected by OA with a very low percentage of complications at short to mid-term follow-up.
- 14 March 2022
- Vol. 93 (1) , e2022135
Open AccessMinimally manipulated adipose derived mesenchymal stromal cells and osteoarthritis: A narrative review.
Human mesenchymal stromal cells (MSCs) have increasingly been used to treat osteoarthritis (OA) related pain and dysfunction, due to their capacity for regeneration and anti-inflammatory effects. Adipose-derived MSCs are characterized by their abundance, ease of access, easy isolation procedures, high lipoaspirate stromal cell production, quicker multiplication of cells, and less pain and morbidity during harvesting. These cells are typically enzymatically derived from adipose tissue but this technique has complicated regulatory problems. To address this problem, a new technique has been created to extract and process adipose tissue without expansion and the use of enzymes to produce autologous minimally manipulated adipose-derived MSCs. Recent studies have confirmed that this treatment is an effective and promising method for treating pain and improving joint function in patients affected by OA with a very low percentage of complications at short to mid-term follow-up.
- Open Access
- 19 January 2022
- Vol. 92 (6) , e2021354
Degenerative meniscal lesions: Conservative versus surgical management.
Degenerative meniscal lesions (DML) typically occur in middle-aged or elderly patients without any history of significant acute trauma. Its prevalence increases with age and are associated with knee osteoarthritis (OA). The most frequent orthopaedic treatment is arthroscopic partial meniscectomy (APM) to relieve pain and functional deficit associated with DML. Nevertheless, several randomised controlled clinical trials recommed against APM as the first-line treatment for managing knee pain in patients affected by DML and no radiographic knee OA that should be reserved for cases of failure after 3 month conservative therapy or earlier in patients with signficant knee mechanical symptoms.
- 19 January 2022
- Vol. 92 (6) , e2021354
Open AccessDegenerative meniscal lesions: Conservative versus surgical management.
Degenerative meniscal lesions (DML) typically occur in middle-aged or elderly patients without any history of significant acute trauma. Its prevalence increases with age and are associated with knee osteoarthritis (OA). The most frequent orthopaedic treatment is arthroscopic partial meniscectomy (APM) to relieve pain and functional deficit associated with DML. Nevertheless, several randomised controlled clinical trials recommed against APM as the first-line treatment for managing knee pain in patients affected by DML and no radiographic knee OA that should be reserved for cases of failure after 3 month conservative therapy or earlier in patients with signficant knee mechanical symptoms.